Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BE Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN121085987A reveals scalable synthesis for 5 beta-carp cholesterol sulfate. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112608281A reveals a room-temperature synthesis of quinazolinones with high purity, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN1247539C details a high-yield route for chiral beta-lactams, offering simplified purification and industrial scalability for API manufacturers.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN108349883B details a novel nickel-catalyzed route for agrochemical intermediates, offering significant cost reduction and scalable manufacturing advantages.
High-purity pharmaceutical intermediate via selective iodination. Cost-effective zeolite process ensures supply chain stability and reduced purification loads for global buyers.
Patent CN111170855A reveals a safer, scalable route for Bempedoic Acid intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved purity profiles.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN103387494A reveals a novel amine-mediated demethylation route for 2-hydroxy-4,5-dimethoxybenzoic acid, offering significant cost reduction and safer manufacturing for Acotiamide intermediates.
Discover a novel high-yield synthesis for Obeticholic Acid intermediates via Weinreb amide protection. Enhance purity to 99.9% and reduce manufacturing costs significantly.
Novel patent CN113880704B offers high-purity 18O-labeled aldehydes. Reduces heavy oxygen water loss and simplifies scale-up for pharmaceutical intermediates manufacturing globally.
Novel two-step route for 18O-labeled aldehydes ensures high purity and reduced isotope loss for scalable pharmaceutical intermediate manufacturing and research applications.
Patent CN107488138B details a high-yield dithiolane-protected route for ezetimibe intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN102212041A details a cost-effective synthesis of chiral cyclic beta-amino aryl butyric acid derivatives with high optical purity suitable for pharmaceutical manufacturing.
Novel cuprous-catalyzed preparation method for 2-amino-6-nitrobenzoic acid. Reduces cost and improves purity for agrochemical and pharmaceutical intermediates supply.
Patent CN112851508A details a safe, scalable route to 3,4-difluoro-2-methylbenzoic acid, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced batch synthesis of dihydrogibberellin from gibberellic acid. High yield, mild conditions, and scalable production for plant growth regulator manufacturing.
Patent CN102093247B reveals a novel silver-mediated acylation route for Tolvaptan intermediates, offering safer conditions and high purity compared to traditional palladium methods.
Patent CN1084166A reveals novel benzothiazolyl methoxy phenyl-acetic acid synthesis. Enables cost reduction in API manufacturing for leukotriene inhibitors.